Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Recruiting · NCT06508775 · Interventional (participants receive a specific treatment) · Lead sponsor: Miltenyi Biomedicine GmbH
View the official record on ClinicalTrials.gov →Interventions studied
MB-CART19.1MB-CART20.1MB-CART2019.1
What this trial is about
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.
- Patient has provided informed consent prior to enrollment.
Exclusion criteria
- No exclusion criteria
Where it is running
7 locations listed.
- Charité Universitätsmedizin Berlin - Berlin, Germany
- Universitätsklinikum Köln - Cologne, Germany
- Uniklinikum Erlangen - Erlangen, Germany
- Universitätsmedizin Göttingen - Göttingen, Germany
- Universitätsklinikum Münster - Münster, Germany
- Universitätsklinikum Tübingen - Tübingen, Germany
- Universitäts-Kinderklinik Würzburg - Würzburg, Germany